Skip to main content

Knowledge Zone

Brief summaries of the market access landscape for medical technologies and in-vitro diagnostic tests in European countries

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Typical profile of the MTRC customers

We are excited to share a detailed overview of the typical clients that MTRC frequently works with. 

  • Our clients mostly have positions in Health Economics and Market Access (HEMA) (70%). The other 12% of our clients hold roles in Operations, 9% in Marketing, and 9% in Sales
  • Overall, 60% have Global responsibilities, while 40% are responsible for the EMEA region
  • Our clients are mostly in senior positions: 50% hold director-level roles. Managers make up 33% of our clients; 10% and 5% are VPs and CEOs respectively
  • Geographically, 71% of our clients are located in Europe; 22% are based in the US, and 7% in other regions
  • Our clients represent both large corporations (74%) and SMEs (26%) with an average of 14 years of industry experience
  • About 45% of our customers come from the top 100 MedTech and IVD companies
  • Within the Med Tech industry, 86% are from medical devices and 14% from in-vitro diagnostic sectors

This dynamic and diverse client base ensures MTRC’s position as one of the most trusted consultants in the MedTech and IVD industry.